Better Buy: Johnson & Johnson vs. Eli Lilly
Longtime leaders, short-term laggards. That's a quick rundown of how Johnson & Johnson (NYSE: JNJ) and Eli Lilly (NYSE: LLY) stocks have performed. While both big pharma stocks have delivered impressive gains for investors over the long run, they've both turned in disappointing results so far in 2019.
There's still plenty to like with J&J and Lilly, but which is the better pick moving forward? Here's how the two stocks compare.
Image source: Getty Images.
Source Fool.com
